ABDULLAH BURAK KARA

Dr. ABDULLAH BURAK KARA

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YBYunus Emre Bulum
Yunus Emre Bulum
AKABDULLAH BURAK KARA
ABDULLAH BURAK KARA
MKMUHAMMED ENES KARATAŞ
MUHAMMED ENES KARATAŞ
MOMehmet Mete Oruç
Mehmet Mete Oruç
ADAbdullah Demirtaş
Abdullah Demirtaş
OPOğuz Şükrü Poyanlı
Oğuz Şükrü Poyanlı
Background/Objectives: Osteochondral lesions are common after acute patellar dislocation, particularly in young, active individuals. Although fixation of osteochondral fragments is a preferred treatment to restore joint congruence and prevent cartilage degeneration, the prognostic effect of lesion localization and size on postoperative outcomes remains unclear. Methods: This retrospective clinical study included 75 patients (mean age 23.8 ± 6.1 years) who underwent osteochondral fixation after patellar dislocation between 2018 and 2024. Lesions were classified by location—medial patellar facet, lateral facet, trochlear groove/lateral femoral condyle, or multiple regions—and measured on preoperative MRI for size and depth. Functional outcomes were assessed using Kujala, Lysholm, Tegner, and VAS pain scores preoperatively and 12 months postoperatively. Associations between lesion characteristics and postoperative results were analyzed using t-tests, ANOVA, and Pearson correlation. Results: Lesions were most frequently located on the medial patellar facet (42.7%), followed by the trochlear groove/lateral femoral condyle (34.7%). Larger and deeper lesions were more common in trochlear or multiple-site involvement (p = 0.002 and p = 0.031, respectively). At final follow-up, all functional scores improved significantly (Kujala: 62.4 ± 11.3 to 86.7 ± 9.1; Lysholm: 64.1 ± 12.0 to 88.2 ± 8.3; VAS: 6.2 ± 1.3 to 2.1 ± 1.1; all p < 0.001). Patients with smaller lesions (<100 mm2) and medial facet involvement achieved higher Kujala scores (p = 0.020) and lower postoperative pain (p = 0.001). The overall return-to-sport rate was 78.7%, and postoperative complications occurred in 10.7% of cases, mainly recurrent dislocation or implant irritation. Conclusions: Lesion localization and size significantly affect postoperative outcomes after osteochondral fixation for patellar dislocation. Medial facet and smaller lesions are associated with better pain relief and functional recovery, whereas large or trochlear lesions carry a less favorable prognosis. Morphological assessment of lesion characteristics should therefore guide surgical planning, fixation strategy, and postoperative rehabilitation to optimize clinical outcomes.

5 May 2026 in Acta Orthopaedica et Traumatologica Turcica
Verified
Journal Article
Open access
PDF file
EKEnes Kanay
Enes Kanay
HBHalil Bulut
Halil Bulut
SDSERDAR DEMİRÖZ
SERDAR DEMİRÖZ
AKABDULLAH BURAK KARA
ABDULLAH BURAK KARA
SBSefa Giray Batıbay
Sefa Giray Batıbay
KOKorhan Ozkan
Korhan Ozkan
Objective: To validate the personalized sarcoma care (PERSARC) tool for predicting overall survival (OS) in a cohort of Turkish patients with soft tissue sarcomas (STS) and to assess its accuracy and clinical utility in a non-Western population. Methods: A retrospective analysis was performed on 100 patients diagnosed with STS between 2017 and 2023. Demographic, clinical, pathological, and treatment-related data were collected. Personalized sarcoma care predictions for OS and disease-free survival were compared with actual outcomes using calibration plots. Predictive performance was evaluated using receiver-operating characteristic analysis and Cox regression models. Results: Of the 100 patients, 59% were male and 57% were older than 50 years. Most tumors were deep-seated (75%) and >10 cm in size (52%). High-grade (Grade 3) tumors were present in 59% of cases. R0 resection was achieved in 95%, with neoadjuvant and adjuvant radiotherapy administered in 46% and 34% of patients, respectively. Local recurrence occurred in 14%, and distant metastases in 27%. At 3-year follow-up, 72% were alive. Personalized sarcoma care predicted 5-year OS as ≤50% in 33%, 51%-75% in 35%, and >75% in 32% of patients. Receiver-operating characteristic analysis demonstrated high predictive performance (area under the curve = 0.844; accuracy = 0.848; sensitivity = 0.607; specificity = 0.944). Personalized sarcoma care score was significantly associated with survival (P < .001), with a C-index of 0.857 (95% CI: 0.769-0.947). Conclusion: The PERSARC model demonstrates high predictive accuracy and calibration for Turkish STS patients, supporting its generalizability beyond Western populations. It offers a robust tool for personalized prognostication in clinical sarcoma care. Prospective validation in larger, diverse cohorts is recommended. Cite this article as: Kanay E, Bulut HI, Demiroz S, et al. Validation of the personalized sarcoma care prognostic tool in Turkish patients with soft tissue sarcomas. Acta Orthop Traumatol Turc., 2026, 60(3), 0583, doi: 10.5152/j.aott.2026.25583.

26 September 2025 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
HBHalil Bulut
Halil Bulut
EKEnes Kanay
Enes Kanay
AKABDULLAH BURAK KARA
ABDULLAH BURAK KARA
SDSERDAR DEMİRÖZ
SERDAR DEMİRÖZ
SBSefa Batibay
Sefa Batibay
KOKorhan Ozkan
Korhan Ozkan